Literature DB >> 15753544

Infection, coagulation, and variceal bleeding in cirrhosis.

U Thalheimer1, C K Triantos, D N Samonakis, D Patch, A K Burroughs.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15753544      PMCID： PMC1774431          DOI： 10.1136/gut.2004.048181

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  79 in total

1.  Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage.

Authors:  J Goulis; A Armonis; D Patch; C Sabin; L Greenslade; A K Burroughs
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

2.  Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence.

Authors:  J M Llovet; R Bartolí; F March; R Planas; B Viñado; E Cabré; J Arnal; P Coll; V Ausina; M A Gassull
Journal:  J Hepatol       Date:  1998-02       Impact factor: 25.083

3.  Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality.

Authors:  M Navasa; A Follo; X Filella; W Jiménez; A Francitorra; R Planas; A Rimola; V Arroyo; J Rodés
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

4.  Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.

Authors:  J C López-Talavera; A Levitzki; M Martínez; A Gazit; R Esteban; J Guardia
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

5.  Inhibition of macrophages with gadolinium chloride alters intercellular adhesion molecule-1 expression in the liver during acute endotoxemia in rats.

Authors:  N Ahmad; C R Gardner; E J Yurkow; D L Laskin
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

Review 6.  Bacterial infections in liver disease.

Authors:  M Navasa; A Rimola; J Rodés
Journal:  Semin Liver Dis       Date:  1997       Impact factor: 6.115

7.  Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis.

Authors:  J P Chin-Dusting; B Rasaratnam; G L Jennings; F J Dudley
Journal:  Ann Intern Med       Date:  1997-12-01       Impact factor: 25.391

8.  Bacterial infection in the pathogenesis of variceal bleeding.

Authors:  J Goulis; D Patch; A K Burroughs
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

Review 9.  The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury.

Authors:  R G Thurman; B U Bradford; Y Iimuro; K T Knecht; G E Arteel; M Yin; H D Connor; C Wall; J A Raleigh; M V Frankenberg; Y Adachi; D T Forman; D Brenner; M Kadiiska; R P Mason
Journal:  J Gastroenterol Hepatol       Date:  1998-09       Impact factor: 4.029

10.  Increased nitric oxide synthesis and inducible nitric oxide synthase expression in patients with alcoholic and non-alcoholic liver cirrhosis.

Authors:  A Sánchez-Rodríguez; M Criado; A M Rodríguez-López; A Esteller; A Martín de Arriba; J M López-Novoa
Journal:  Clin Sci (Lond)       Date:  1998-06       Impact factor: 6.124
View more
  68 in total

Review 1.  Acute variceal bleeding: risk stratification and management (including TIPS).

Authors:  Virginia Hernández-Gea; Claudia Berbel; Anna Baiges; Juan C García-Pagán
Journal:  Hepatol Int       Date:  2017-06-20       Impact factor: 6.047

Review 2.  Mortality from cirrhosis: lack of progress over the last 35 years.

Authors:  C Gluud
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

Review 3.  Current management of the complications of portal hypertension: variceal bleeding and ascites.

Authors:  Nina Dib; Frédéric Oberti; Paul Calès
Journal:  CMAJ       Date:  2006-05-09       Impact factor: 8.262

Review 4.  New insights into the coagulopathy of liver disease and liver transplantation.

Authors:  M Senzolo; P Burra; E Cholongitas; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

Review 5.  Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.

Authors:  Dmitry Victorovich Garbuzenko
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 6.  Markers of bacterial translocation in end-stage liver disease.

Authors:  Ioannis Koutsounas; Garyfallia Kaltsa; Spyros I Siakavellas; Giorgos Bamias
Journal:  World J Hepatol       Date:  2015-09-18

Review 7.  Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Authors:  Valerio Giannelli; Vincenza Di Gregorio; Valerio Iebba; Michela Giusto; Serena Schippa; Manuela Merli; Ulrich Thalheimer
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

8.  Pulmonary resection for non-small cell lung cancer in patients with hepatocellular carcinoma.

Authors:  Takashi Iwata; Noritoshi Nishiyama; Koshi Nagano; Nobuhiro Izumi; Shinjiro Mizuguchi; Ryuhei Morita; Takuma Tsukioka; Shoji Hanada; Kiyotoshi Inoue; Shoji Kubo; Shigekazu Takemura; Shigefumi Suehiro
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

9.  Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study.

Authors:  Chung-Hwan Jun; Chang-Hwan Park; Wan-Sik Lee; Young-Eun Joo; Hyun-Soo Kim; Sung-Kyu Choi; Jong-Sun Rew; Sei-Jong Kim; Young-Dae Kim
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

10.  Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?

Authors:  Maria Papp; Gary L Norman; Zsuzsanna Vitalis; Istvan Tornai; Istvan Altorjay; Ildiko Foldi; Miklos Udvardy; Zakera Shums; Tamas Dinya; Peter Orosz; Bela Lombay; Gabriella Par; Alajos Par; Gabor Veres; Timea Csak; Janos Osztovits; Ferenc Szalay; Peter Laszlo Lakatos
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.